Evidence map›Paper›PMID 41612972›Full record

ArticleGut microbes2026

Francesco Marrocco, Germana Cocozza, Fabrizio Antonangeli, Rizwan Khan, Giuseppe Pietropaolo, Abdechakour Elkihel, Gabriele Favaretto, Xingzi Lin, Romina Mancinelli, Ludovica Maria Busdraghi and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Correlative study ofFrontiers in microbiology · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Francesco MarroccoDepartment of Physiology and Pharmacology, Sapienza University, Rome, Italy.ORCID 0000-0002-2732-9119
Germana CocozzaDepartment of Physiology and Pharmacology, Sapienza University, Rome, Italy.
Fabrizio AntonangeliInstitute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, Italy.
Rizwan KhanDepartment of Physiology and Pharmacology, Sapienza University, Rome, Italy.
Giuseppe PietropaoloDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy. Laboratory affiliated to Istituto Pasteur Italia, Rome, Italy.
Abdechakour ElkihelAix-Marseille Université, Center Interdisciplinaire de Nanoscience de Marseille, UMR 7325, Equipe Labellisée Ligue Contre le Cancer, CNRS, Marseille, France.
Gabriele FavarettoInstitute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, Italy.
Xingzi LinDepartment of Physiology and Pharmacology, Sapienza University, Rome, Italy.
Romina MancinelliSection of Human Anatomy, Department of Anatomic, Histologic, Forensic Medicine and Locomotor Apparatus Sciences, Sapienza University of Roma, Roma, Italy.
Ludovica Maria BusdraghiDepartment of Physiology and Pharmacology, Sapienza University, Rome, Italy.
Alice ReccagniDepartment of Physiology and Pharmacology, Sapienza University, Rome, Italy.
Gianluca ScarnoDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy. Laboratory affiliated to Istituto Pasteur Italia, Rome, Italy.
Giuseppe SciumèDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy. Laboratory affiliated to Istituto Pasteur Italia, Rome, Italy.
Mattia LaffranchiDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy. Laboratory affiliated to Istituto Pasteur Italia, Rome, Italy.
Ling PengAix-Marseille Université, Center Interdisciplinaire de Nanoscience de Marseille, UMR 7325, Equipe Labellisée Ligue Contre le Cancer, CNRS, Marseille, France.
Valerio IebbaGustave Roussy Cancer Campus, ClinicObiome, Villejuif, France.
Silvano SozzaniDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy. Laboratory affiliated to Istituto Pasteur Italia, Rome, Italy.
Giuseppina D'AlessandroDepartment of Physiology and Pharmacology, Sapienza University, Rome, Italy.ORCID 0000-0001-7220-6065
Cristina LimatolaIRCCS Neuromed, Pozzilli, IS, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GBM) is the most common and malignant brain tumor in adult humans. Recent studies have demonstrated a link between the composition of the gut microbiota and glioma progression. Here, we describe that the growth of glioma in mice is inversely correlated with the relative abundance of the anaerobic bacterium

Indexed as

Brain NeoplasmsGliomaToll-Like Receptor 2AnimalsCD8-Positive T-LymphocytesFecesGastrointestinal MicrobiomeHumansMaleMiceMice, Inbred C57BLMicrogliaTumor Necrosis Factor-alphaTlr2 protein, mouseToll-Like Receptor 2Tumor Necrosis Factor-alphaGliomagut microbiotaimmune cell activationMuribaculum intestinale

Identifiers

PMID41612972
PMCPMC12867398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.